These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8098425)

  • 21. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients.
    Bouchaud O; Basco LK; Gillotin C; Gimenez F; Ramiliarisoa O; Genissel B; Bouvet E; Farinotti R; Le Bras J; Coulaud JP
    Am J Trop Med Hyg; 1994 Aug; 51(2):204-13. PubMed ID: 8074254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model.
    Singh N; Puri SK
    Life Sci; 2000 Aug; 67(11):1345-54. PubMed ID: 10972203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial drug resistance and mortality in falciparum malaria.
    White N
    Trop Med Int Health; 1999 Jul; 4(7):469-70. PubMed ID: 10470336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug resistant tropical malaria in the Republic of Guinea (West Africa)].
    Popov AF; Popova NI; Chirkov VP; Kamara F
    Med Parazitol (Mosk); 2003; (2):41-3. PubMed ID: 12886592
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malaria historians: analyze your old slides!
    Sibley CH
    Trends Parasitol; 2006 Jun; 22(6):243-4. PubMed ID: 16632405
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: antimalarial drug discovery and design in the era of resistance.
    Bell A
    Curr Pharm Des; 2013; 19(2):264-5. PubMed ID: 22973889
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cross resistance to mefloquine and halofantrine in a case of P. falciparum malaria contracted in Sierra Leone].
    Félix R; Gay F; Lyogoubi A; Bustos MD; Diquet B; Danis M; Gentilini M
    Bull Soc Pathol Exot; 1990; 83(1):43-5. PubMed ID: 2190703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is the in vivo test for resistance to antimalarial agents in malaria as defined by the WHO valid?].
    Cabezos J; Bada JL; Asmarats L
    Med Clin (Barc); 1992 Oct; 99(11):436. PubMed ID: 1469944
    [No Abstract]   [Full Text] [Related]  

  • 30. Chloroquine resistant Plasmodium falciparum in migrant population.
    Srivastava HC; Sharma SK
    Indian J Malariol; 2000; 37(1-2):39-42. PubMed ID: 11820081
    [No Abstract]   [Full Text] [Related]  

  • 31. Activity in vitro of the enantiomers of halofantrine.
    Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
    Trans R Soc Trop Med Hyg; 1993; 87(1):78-9. PubMed ID: 8465405
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug sensitivity of Plasmodium falciparum in vivo and in vitro in Brazzaville (Congo)].
    Chandenier J; Ndounga M; Carme B; Gay F; Mbitsi A; Hayette MP; Stanghellini A; Ossoh JO; Baudon D; Zitsamélé RC
    Sante; 1995; 5(1):25-9. PubMed ID: 7894826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloroquine resistant malaria in children.
    Memon IA; Kanth N; Murtaza G
    J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
    Al-Yaman F; Genton B; Mokela D; Alpers MP
    P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
    [No Abstract]   [Full Text] [Related]  

  • 35. Population genetics: malaria variorum.
    Clark AG
    Nature; 2002 Jul; 418(6895):283-5. PubMed ID: 12124606
    [No Abstract]   [Full Text] [Related]  

  • 36. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mefloquine resistance in Plasmodium falciparum malaria].
    Garavelli PL
    Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
    [No Abstract]   [Full Text] [Related]  

  • 38. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 39. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum.
    Chen N; Russell B; Staley J; Kotecka B; Nasveld P; Cheng Q
    J Infect Dis; 2001 May; 183(10):1543-5. PubMed ID: 11319698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.